Les inhibiteurs de JAK dans la maladie de Still réfractaire
L. Gillard(Sorbonne Université), Héloïse Reumaux(Hôpital Jeanne de Flandre), Bruno Fautrel, Stéphane Mitrovic(Sorbonne Université), Martin Michaud(Centre Hospitalier Universitaire de Toulouse), Isabelle Koné‐Paut(Université Paris-Saclay), J. Pouchot(Hôpital Européen Georges-Pompidou)
Cited by 0
Related Papers
Proinflammatory Cytokines, Aging, and Age-Related Diseases
|Journal of the American Medical Directors Association|2013|1.1k
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
|New England Journal of Medicine|2009|857
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
|The Lancet Rheumatology|2021|292